-transparent.png){kind=logo}
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019. 2020
Wei Cao, and
Xiaosheng Liu, and
Tao Bai, and
Hongwei Fan, and
Ke Hong, and
Hui Song, and
Yang Han, and
Ling Lin, and
Lianguo Ruan, and
Taisheng Li
Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Wei Cao, and
Xiaosheng Liu, and
Tao Bai, and
Hongwei Fan, and
Ke Hong, and
Hui Song, and
Yang Han, and
Ling Lin, and
Lianguo Ruan, and
Taisheng Li
January 2020,
Frontiers in pharmacology,
Wei Cao, and
Xiaosheng Liu, and
Tao Bai, and
Hongwei Fan, and
Ke Hong, and
Hui Song, and
Yang Han, and
Ling Lin, and
Lianguo Ruan, and
Taisheng Li
May 2020,
European review for medical and pharmacological sciences,
Wei Cao, and
Xiaosheng Liu, and
Tao Bai, and
Hongwei Fan, and
Ke Hong, and
Hui Song, and
Yang Han, and
Ling Lin, and
Lianguo Ruan, and
Taisheng Li
June 2021,
BMJ case reports,
Wei Cao, and
Xiaosheng Liu, and
Tao Bai, and
Hongwei Fan, and
Ke Hong, and
Hui Song, and
Yang Han, and
Ling Lin, and
Lianguo Ruan, and
Taisheng Li
October 2019,
Journal of child neurology,
Wei Cao, and
Xiaosheng Liu, and
Tao Bai, and
Hongwei Fan, and
Ke Hong, and
Hui Song, and
Yang Han, and
Ling Lin, and
Lianguo Ruan, and
Taisheng Li
February 2021,
Internal medicine (Tokyo, Japan),
Wei Cao, and
Xiaosheng Liu, and
Tao Bai, and
Hongwei Fan, and
Ke Hong, and
Hui Song, and
Yang Han, and
Ling Lin, and
Lianguo Ruan, and
Taisheng Li
January 2022,
Chinese medical journal,
Wei Cao, and
Xiaosheng Liu, and
Tao Bai, and
Hongwei Fan, and
Ke Hong, and
Hui Song, and
Yang Han, and
Ling Lin, and
Lianguo Ruan, and
Taisheng Li
January 2021,
Nutrition (Burbank, Los Angeles County, Calif.),
Wei Cao, and
Xiaosheng Liu, and
Tao Bai, and
Hongwei Fan, and
Ke Hong, and
Hui Song, and
Yang Han, and
Ling Lin, and
Lianguo Ruan, and
Taisheng Li
March 2022,
Complementary therapies in medicine,
Wei Cao, and
Xiaosheng Liu, and
Tao Bai, and
Hongwei Fan, and
Ke Hong, and
Hui Song, and
Yang Han, and
Ling Lin, and
Lianguo Ruan, and
Taisheng Li
November 2020,
Critical care explorations,
Wei Cao, and
Xiaosheng Liu, and
Tao Bai, and
Hongwei Fan, and
Ke Hong, and
Hui Song, and
Yang Han, and
Ling Lin, and
Lianguo Ruan, and
Taisheng Li
August 2021,
Cureus,
